本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

104.71
+2.512.46%
盤後104.710.00000.00%19:30 EDT
成交量:57.37萬
成交額:6,014.22萬
市值:72.10億
市盈率:-33.59
高:106.57
開:102.96
低:102.25
收:102.20
52周最高:122.20
52周最低:74.50
股本:6,885.21萬
流通股本:6,539.41萬
量比:1.33
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
淨資產收益率:-117.04%
總資產收益率:-30.96%
市淨率:70.01
市盈率(LYR):-33.67

資料載入中...

2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

重要事件披露

8-K - Current report
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

重要事件披露

8-K - Current report
2021/02/03

重要事件披露

8-K - Current report
2021/02/01

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/05

重要事件披露

8-K - Current report
2021/01/04

重要事件披露

8-K/A [Amend] - Current report
2020/12/11

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/02

重要事件披露

8-K - Current report
2020/09/16

重要事件披露

8-K - Current report
2020/08/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]